Xie et al. (28) showed that ERK pathway activation inhibits the expression of FOXO1; however, we found a significant decrease of ET-1 and FOXO1 expression after inhibiting ERK phosphorylation by the MEK inhibitor PD0325901 in gastric cancer. Here, FOXO1 is linked to gastric cancer.